Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Natus Medical Inc : Natus Medical to Hold 2012 First Quarter Financial Results Conference Call on April 26

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2012 | 01:05pm CET

Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company intends to release its 2012 first quarter financial results before the market opens on Thursday, April 26, 2012. Natus management will host an investment-community conference call the same day beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing 888-268-4176 for domestic callers, or 1-617-597-5493 for international callers, and entering reservation code 32875965. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 888-286-8010 for domestic callers, or 1-617-801-6888 for international callers, and entering reservation code 56980616.

The conference call also will be available real-time via the Internet at http://investor.natus.com, and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, 650-802-0400
InvestorRelations@Natus.com
Vice President and Chief Financial Officer


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
01/09 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) Files An 8-K Results of Operations an..
01/09 NATUS MEDICAL INC : Results of Operations and Financial Condition, Financial Sta..
01/09 Natus Medical Announces 2017 Annual and First Quarter Financial Guidance
01/05 NATUS MEDICAL : Global Portable Vascular Doppler Market 2017 Atys Medical, Newma..
01/03 NATUS MEDICAL : GN Hearing Announces Divestment of Otometrics
01/03 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) Files An 8-K Completion of Acquisitio..
01/03 NATUS MEDICAL INC : Completion of Acquisition or Disposition of Assets, Financia..
01/03 Natus Completes Acquisition of GN Otometrics Business
2016 Natus to Present at J.P. Morgan 35th Annual Healthcare Conference
2016 Natus to Present at 28th Annual Piper Jaffray Healthcare Conference
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
2016 EXCLUSIVE : U.S. regulator poised to approve Abbott purchase of St Jude - source..
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/09 Natus expects bullish 2017; shares ahead 5%
2016 Get 'BABY' On Board
2016 INSIDERINSIGHTS.COM DAILY ROUND UP 1 : Adc, erc, fsd
2016 Natus Medical's (BABY) CEO Jim Hawkins on Q3 2016 Results - Earnings Call Tra..
2016 Natus Medical Q3 revenues off 4%; earnings up 21% in Q3; updates guidance
Advertisement
Financials ($)
Sales 2016 382 M
EBIT 2016 66,4 M
Net income 2016 48,2 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 26,54
P/E ratio 2017 24,07
Capi. / Sales 2016 3,34x
Capi. / Sales 2017 2,80x
Capitalization 1 275 M
More Financials
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Full-screen chart
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 48,3 $
Spread / Average Target 25%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy Chief Financial Officer, EVP & IR Contact
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC11.35%1 275
THERMO FISHER SCIENTIF..3.68%57 788
DANAHER CORPORATION4.52%56 277
BOSTON SCIENTIFIC CORP..10.12%32 435
PHILIPS-0.41%28 566
INTUITIVE SURGICAL, IN..4.82%25 756
More Results